Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.

Saved in:
Bibliographic Details
Title: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
Authors: Kameda S; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan., Fujii T; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan. tofujii-tky@umin.net., Ikeda J; Department of Clinical Engineering Technology, The Jikei University Hospital, Tokyo, Japan., Kageyama A; Department of Pharmacy, The Jikei University Hospital, Tokyo, Japan., Takagi T; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan., Miyayama N; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan., Asano K; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan., Endo A; Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-Ku, 105-8471, Tokyo, Japan., Uezono S; Department of Anesthesiology, The Jikei University Hospital, Tokyo, Japan.
Source: BMC nephrology [BMC Nephrol] 2023 Jan 16; Vol. 24 (1), pp. 12. Date of Electronic Publication: 2023 Jan 16.
Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2369
DOI:10.1186/s12882-023-03060-1